ABSTRACT
The purpose of this review is to summarize the epidemiologic and clinical trial evidence for estrogen’s physiologic role in skeletal health among aging women. Emerging data from these studies indicate a need to redefine the levels at which estrogen physiologic adequacy is achieved, and support the use of much lower estrogen doses than are currently prescribed.
